Testing effectiveness (Phase 2)Temporarily pausedNCT01325740
What this trial is testing
Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome
Who this might be right for
Fragile X Syndrome
Seaside Therapeutics, Inc. 16